Novo A/S 13D and 13G filings for LAVA Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-07 7:09 pm Sale | 2024-03-05 | 13D | LAVA Therapeutics N.V. LVTX | Novo A/S | 0 0.000% | -1,878,194 (Position Closed) | Filing |
| 2023-11-09 4:37 pm Sale | 2023-11-03 | 13D | LAVA Therapeutics N.V. LVTX | Novo A/S | 1,878,194 7.100% | -521,806 (-21.74%) | Filing |
| 2023-06-05 8:18 pm Sale | 2023-06-05 | 13D | LAVA Therapeutics N.V. LVTX | Novo A/S | 2,400,000 9.130% | -670,558 (-21.84%) | Filing |
| 2023-02-24 4:38 pm Sale | 2023-02-22 | 13D | LAVA Therapeutics N.V. LVTX | Novo A/S | 3,070,558 11.700% | -256,754 (-7.72%) | Filing |
| 2022-10-03 4:15 pm Unchanged | 2022-09-27 | 13D | LAVA Therapeutics N.V. LVTX | Novo A/S | 3,327,312 12.900% | 0 (Unchanged) | Filing |
| 2022-09-30 4:45 pm Unchanged | 2022-04-21 | 13D | LAVA Therapeutics N.V. LVTX | Novo A/S | 3,327,312 8.600% | 0 (Unchanged) | Filing |
| 2021-03-31 4:33 pm Purchase | 2021-03-24 | 13D | LAVA Therapeutics N.V. LVTX | Novo A/S | 3,327,312 13.100% | 3,327,312 (New Position) | Filing |